| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |